ZIMTHRU Trademark
Trademark Overview
On Monday, January 29, 2024, a trademark application was filed for ZIMTHRU with the United States Patent and Trademark Office. The USPTO has given the ZIMTHRU trademark a serial number of 98381207. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 26, 2024. This trademark is owned by Renibus Therapeutics, Inc.. The ZIMTHRU trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for preventing heart disease progression; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement
General Information
Serial Number | 98381207 |
Word Mark | ZIMTHRU |
Filing Date | Monday, January 29, 2024 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, November 26, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 26, 2024 |
Trademark Statements
Goods and Services | Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for preventing heart disease progression; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, January 29, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Renibus Therapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Southlake, TX 76092 |
Party Name | Renibus Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Southlake, TX 76092 |
Trademark Events
Event Date | Event Description |
Monday, January 29, 2024 | NEW APPLICATION ENTERED |
Tuesday, May 28, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, August 23, 2024 | ASSIGNED TO EXAMINER |
Monday, September 2, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, September 2, 2024 | NON-FINAL ACTION WRITTEN |
Monday, September 2, 2024 | NON-FINAL ACTION E-MAILED |
Thursday, October 31, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, October 31, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, October 31, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, November 1, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, November 20, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, November 26, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, November 26, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |